CD8A and neoplasm: We believe that the approach we have developed – tracking of immunostained CD8 T cells in fresh human tumor tissue with imaging technology – could be used as pre-clinical model system in which novel immunotherapy treatments and especially those designed to boost T cell migration can be assessed and optimized in conditions close to the clinic.